Amersham logo'It all makes sense...' - Annual Report & Accounts 2002
DownloadsReport homepageMain website
Corporate governance statement (continued) Next page
Previous page
 

The Nomination Committee
The Nomination Committee met six times during the year to review the composition of, and succession to, the Board and makes recommendations to the Board on the appointment of Non-Executive and Executive Directors. The Committee comprises seven of the independent Non-Executive Directors and is chaired by Mr J Fr Odfjell, the Deputy Chairman of the Board. The Nomination Committee reviews the composition of the Board in light of corporate governance regulation and best practice, both current and proposed.

Members of the Committee abstain when matters affecting their own appointments are discussed. The Committee has available to it the services of external advisers as it deems necessary and at the company's expense. The Chief Executive attends the meetings of the Nomination Committee.

The Remuneration Committee
The Remuneration Committee met four times during the year. The Remuneration Committee is responsible for determining the remuneration policy and the terms and conditions of service of the Executive Directors. The Remuneration Committee also determines group policy relating to share option plans and the level at which share options are granted to senior executives within the group. The Committee has available to it the services of independent advisers. The Committee comprises six of the independent Non-Executive Directors including the Chairman and Deputy Chairman of the Board and is chaired by Mr R D Lapthorne, the Chairman of the Board. Following the retirement of Mr R D Lapthorne at the Annual General Meeting to be held on 7 May 2003, the Remuneration Committee will be chaired by Dr J S Patterson. The principal terms of reference of the Remuneration Committee appear in the Remuneration report. The Chief Executive and the Human Resources Director attend the meetings of the Committee to discuss the performance of the other Executive Directors and to make proposals as necessary but they are not present when their own remuneration is being considered.

The Audit Committee
The Audit Committee met four times during the year. The Audit Committee monitors and reviews the internal controls and accounts of the group. It also considers the group's compliance with the Combined Code. The Committee is chaired by Mr D H Brydon. The Committee comprises four further independent Non-Executive Directors: Mr R D Lapthorne, Mr J Fr Odfijell, Dr J S Patterson and Mr J F Rejeange. The Committee can request the external auditors, who are normally present, Executive Directors and other officers of the group to attend its meetings. The Audit Committee receives regular reports from the Risk and Operational Review department on all aspects of the group's system of internal control. The Audit Committee recommends the appointment of the external auditors, reviews the external audit fee and audit plan and pre-approves all non-audit work in respect of the external auditors prior to commitment.

Disclosure Committee
As recommended in the provisions of the US Sarbanes-Oxley Act, a Disclosure Committee, chaired by Mr G F B Kerr and comprising relevant senior managers, has been established to ensure a robust verification and disclosure control process throughout the group. This will enable the Chief Executive and the Finance Director (CFO) to make the certifications as required by the legislation. The Disclosure Committee reports directly into the Chief Executive.

Appointments to the Board
Any Director appointed during the year is required, under the provisions of the company's Articles of Association, to retire and seek re-appointment by shareholders at the next Annual General Meeting. The Articles also require that one-third of the Directors retire by rotation each year and seek re-appointment at the Annual General Meeting. The Directors required to retire will be those in office longest since their previous appointment or re-appointment and this will usually mean that each Director retires at least every three years. The Board has resolved that each Director will retire at least every three years, even if this is not strictly required by the application of the provisions of the Articles of Association.

Compliance
In addition to the Principles of Good Governance, the Combined Code also contains a Code of Best Practice detailing some forty-five provisions. The Board has carried out a full internal review of compliance with its provisions. The Board confirms that the company has complied with these provisions throughout the financial year. The company also complies to the extent applicable for foreign registrants with the US Sarbanes-Oxley Act.

Internal control
The Board is responsible for the group's system of internal control and for reviewing its effectiveness. Any system of internal control can only be designed to manage rather than eliminate the risk of failure to achieve business objectives, and can provide only reasonable and not absolute assurance against material misstatement or loss.

The Board confirms that it has applied Principle D.2 of the Combined Code in that there is an ongoing process for identifying, evaluating and managing the significant risks faced by the group, which has been in place for the year 2002 and up to the date of approval of the Annual Report & Accounts. The Board also confirms that this process is regularly reviewed by the Board and is in accord with Internal Control: Guidance for Directors on the Combined Code published in September 1999.

In accordance with provision D.2.1 the Board, including the appropriate subcommittees, regularly reviews the effectiveness of the group's internal control processes. Key elements of the group's system of internal controls are set out below:

Control environment
The group is committed to high standards of business conduct and seeks to maintain these standards across all of its operations throughout the world. The group has in place group finance policies, a code of business conduct and employee procedures.

The group has an appropriate organisational structure for planning, executing, controlling and monitoring business operations in order to achieve objectives. Lines of responsibility and delegations of authority are documented.

Identifying and evaluating risk
The identification and evaluation of risk in the business is approached at different levels. This encompasses both:

- senior management's assessment of the group's risk profile in terms of the achievement of strategic objectives; and
- a structured assessment of risks operating within entities and functions.

This process also involves assessing the probability, impact and the required actions for appropriately managing risks as identified. The group seeks to understand the risks that it faces across the following broad categories:

- external risks arising from, for example, market, competitor or regulatory issues
- informational risks concerning the integrity and availability of management information
- operational risks arising from, for instance, the management of our supply chain or our manufacturing processes
- financial risks associated with our budget and planning, liquidity position or the management of our credit
- strategic risks relating to our product portfolio or our planning.

Operational management is responsible for the identification and evaluation of key risks applicable to their areas of business. The group has a formal risk identification and review process facilitated by a dedicated function, which assists management in the process. This function reports these risks to both the Audit Committee and the Board on a regular basis.

Performance monitoring
Group businesses participate in periodic strategic reviews, which include the consideration of long term financial projections and the evaluation of business alternatives. Operating units prepare annual budgets and five-year strategic plans; performance against plan is actively monitored at the Board and business unit level supported by regular forecasts. Forecasts and results are consolidated and presented to the Board on a regular basis.

Control procedures
The group and its operating units have implemented control procedures designed to ensure complete and accurate accounting for financial transactions and to limit the potential exposure to loss of assets or fraud. Measures taken include physical controls, segregation of duties, reviews by management and operational review, and external audit to the extent necessary to arrive at their audit opinion.

A process of control, self-assessment and hierarchical reporting has been established which provides for a documented audit trail of accountability. These procedures are relevant across group operations and provide for successive assurances to be given at increasingly higher levels of management and, finally, to the Board. These documents are reviewed by the Risk and Operational Review department for completeness and accuracy. Planned corrective actions are independently monitored for timely completion. These processes have been reviewed and where necessary revised in light of the US Sarbanes-Oxley Act.

Going concern
After making enquiries the Directors have reasonable expectation that the company and the group have adequate resources to continue in operational existence for the foreseeable future, and that it is therefore appropriate to adopt the going concern basis in preparing the financial statements. In forming this view the Directors have reviewed the Annual Profit Plan for the year ending 31 December 2003 and strategic plan projections for subsequent years. The Directors have satisfied themselves that the group is in a sound financial position and that sufficient borrowing facilities will be available to meet the group's foreseeable cash requirements.

On behalf of the Board
R D Lapthorne, Chairman
26 February 2003

 
Investor tools:
Search this site
Print this page
Download PDF

Next page
Previous page

© Amersham plc - All rights reserved  Privacy policy - Terms & conditions - GE Healthcare